Beta blockers
-
Upload
drshah-murad -
Category
Education
-
view
16.474 -
download
17
description
Transcript of Beta blockers
![Page 1: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/1.jpg)
PROF. DR. SHAH MURADSHAHMURAD65@GMAIL .COM
Beta adrenergic receptor antagonists or beta-
blockers
![Page 2: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/2.jpg)
Beta blockers are prescription medications used to treat many different conditions, such as high blood pressure (hypertension) or irregular heart rhythms (arrhythmias).
There are numerous different beta blockers available, and there are several important differences among the various beta blockers
![Page 3: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/3.jpg)
Beta Blockers By Type
Usually, beta blockers are categorized in a few different ways.
Some are "cardioselective" (meaning they are more likely to affect the heart and blood vessels rather than other parts of the body), some have "intrinsic sympathomimetic activity" ( slightly stimulate beta receptors while also blocking them), and some are alpha blockers as well as beta blockers.
some beta blockers fall into more than one category
![Page 4: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/4.jpg)
Cardioselective beta blockers
AcebutololAtenololBetaxololBisoprololEsmololNebivololMetoprolol
![Page 5: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/5.jpg)
Beta blockers with intrinsic sympathomimetic activity (ISA)
Acebutolol
Carteolol
Penbutolol
Pindolol
![Page 6: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/6.jpg)
Beta blockrs + alpha-blockade
CARVEDILOL
LABETALOL
![Page 7: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/7.jpg)
Beta blockers that are non-selective, do not have ISA, and do not block alpha
receptors
Levobunolol MetipranololNadololPropranololSotalolTimolol
![Page 8: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/8.jpg)
Sotalol is unique among beta blockers in that it also blocks potassium channels in the heart.
![Page 9: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/9.jpg)
Drugs which inhibit beta adrenergic receptors are called beta -blocking agents and also beta-blockers.
They inhibit competitively the beta effects of endogenous catecholamines.
![Page 10: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/10.jpg)
To understand the consequences of inhibition of beta receptors , it is necessary to keep in mind the effects of stimulation of beta receptors.
![Page 11: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/11.jpg)
The stimulation of the postsynaptic beta-1 receptors induces:
cardiac inotropic, chronotropic, dromotropic and bathmotropic positive effects with increase of cardiac output and oxygen requirement.
increase of renin secretion.
![Page 12: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/12.jpg)
The stimulation of the postsynaptic beta-2 receptors induces:
vasodilation, bronchodilatation, uterine relaxation, metabolic effects, cardiac inotropic and chronotropic positive effects but less than those which result from beta-1 stimulation.
The stimulation of presynaptic beta-2 receptors increases noradrenaline release.
![Page 13: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/13.jpg)
The inhibition of beta adrenergic receptors elicits a decrease or a suppression of the effects of endogenous catecholamines.
The effects are more important when endogenous stimulation is there.
nhibition of beta receptors has beneficial and adverse effects
![Page 14: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/14.jpg)
Common effects
The effects of beta-blockers are primarily cardiovascular.
They slow heart rate by decreasing the slope of slow diastolic depolarization and constitute group II of antiarrhythmic drugs.
They decrease heart oxygen requirement, which explains their use in the preventive treatment of angina pectoris
![Page 15: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/15.jpg)
They decrease, after a latency period, pathological arterial hypertension, by complex mechanisms, decrease of cardiac output, inhibition of renin secretion, and perhaps inhibition of the sympathetic tone by a central effect.
![Page 16: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/16.jpg)
But they are not true hypotensive agents because they do not lower, at therapeutic doses, normal arterial pressure.
Beta-blockers lower intraocular pressure by decreasing aqueous humor secretion.
![Page 17: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/17.jpg)
Particular effects
Some beta-blockers have a slight beta-mimetic activity, called intrinsic sympathomimetic activity or ISA, whose consequence is that a low beta stimulation persists.
They have a high affinity for beta receptors but no or only a low capacity to activate these receptors.
![Page 18: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/18.jpg)
Being bound to beta receptors, they prevent endogenous catecholamines from inducing beta effects and are thus true beta-blockers.
![Page 19: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/19.jpg)
Beta-blockers are classified according their selective inhibition of beta-1 and/or beta-2receptors.
Some beta-blockers inhibit at the same time beta-1 and beta-2 receptors, others inhibit only beta-1 receptors.
The latter are known as cardio-selective.
It did not appear interesting in therapeutics to selectively inhibit beta-2 receptors.
![Page 20: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/20.jpg)
In addition to their beta-blocking activity, some beta-blockers like propranolol and acebutolol, have a membrane-stabilizing effect which reduces transmembrane ion exchanges.
This activity, sometimes called local anesthetic or antiarrhythmic effect, results from a decrease of the rate of depolarization by sodium entry.
![Page 21: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/21.jpg)
Labetolol and carvedilol have an alpha-1-blocking effect, celiprolol a beta-2-agonist effect.
Propranolol inhibits the transport of iodine in the thyroid follicle.
Carvedilol would have, at least in vitro, antioxydant properties.
Nebivolol has a NO-mimetic vasodilatator effect.
![Page 22: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/22.jpg)
Pharmacokinetic features
One can distinguish liposoluble and water-soluble beta-blockers.
liposoluble beta-blockers like propranolol and oxyprenolol have common features:
![Page 23: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/23.jpg)
they are quickly and completely absorbed by the digestive tract.
they are metabolized in the liver and can undergo an inactivation known as first metabolism.
Their ingestion with foods can reduce the importance of first-pass metabolism and increase their bioavailability.
![Page 24: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/24.jpg)
-they are bound at 90% to plasma proteins.
-they have a very great volume of distribution, i.e. they diffuse readily in tissues.
-they have a rather short duration of action and a short plasma half-life
![Page 25: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/25.jpg)
water-soluble beta-blockers like atenolol, nadolol and sotalol have the following properties:
they are less quite absorbed by the digestive tract and in a more irregular way
they are little metabolized by the liver
they are not very bound to plasma proteins
![Page 26: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/26.jpg)
they are eliminated primarily by the kidney in unchanged form
they have a restricted volume of distribution
they have a long plasma half-life
![Page 27: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/27.jpg)
Between these two extremes, very liposoluble beta-blockers and very water-soluble beta-blockers, there are intermediate products such as pindolol and celiprolol.
![Page 28: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/28.jpg)
![Page 29: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/29.jpg)
Therapeutic uses
Cardiovascular uses-angina pectoris: in prevention of attacks
-tachycardia of various origins including those of hyperthyroidism, in particular the of Gravé's disease where one uses especially propranolol
-arterial hypertension
-myocardial infarction,
-unstable angina
![Page 30: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/30.jpg)
-congestive heart failure, an apparent paradoxical indication.
-Actually, there is in patients with congestive heart failure a sympathetic overstimulation with an increase of plasma noradrenaline concentration and a decrease of beta receptors reactivity.
-Inhibition of beta receptors can, by withdrawing the heart from the sympathetic overstimulation, improve its activity.
![Page 31: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/31.jpg)
Starting treatment of congestive heart failure by beta-blockers requires a narrow monitoring.
The three beta-blockers having shown efficacy in this therapeutic use are bisoprolol, metoprolol and carvedilol.
It is possible that beta-blockers having alpha-1 antagonist effect like carvedilol, are more appropriate in this indication
![Page 32: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/32.jpg)
Other therapeutic uses
prevention of primary and secondary digestive bleeding in portal hypertension by rupture of esophageal varices; propranolol is usually used
![Page 33: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/33.jpg)
-treatment of migraine, tremor, transitory somatic symptoms of anxiety, alcohol addiction in which there appears a beta overstimulation.
-In this case propranolol is usually prescribed
-treatment of glaucoma by ophthalmic solutions, but they can diffuse into the general circulation and give adverse effects
![Page 34: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/34.jpg)
Generally dosage of beta-blockers must be gradually increased at the beginning of the treatment and gradually decreased at cessation with monitoring and rest
![Page 35: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/35.jpg)
Available preparations
Beta-blockers are presented in the form of tablets or of capsules, some of them in injectable form are intended for treatment of acute disorders of heart rhythm and acute phase of myocardial infarction.
![Page 36: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/36.jpg)
Beta-blockers, not cardioselective, without Intrinsic sympathomimetic activity are propranolol, nadolol, sotalol, tertatolol, timolol, labetolol, carvedilol
![Page 37: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/37.jpg)
Beta-blockers not cardioselective, with ASI. oxyprenolol ; carteolol and pindolol
![Page 38: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/38.jpg)
Beta1-blockers, cardioselective, without A.S.I. atenolol ; betaxolol, bisoprolol, metoprolol, esmolol and nebivolol
![Page 39: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/39.jpg)
Bêta1-blockers, cardioselective, with A.S.I. Acebutolol, Celiprolol
![Page 40: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/40.jpg)
Beta-blockers combined with a diuretic.
Many beta-blockers are combined under proprietary names with a diuretic such as hydrochlorothiazide, chortalidone, clopamide, amiloride.
![Page 41: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/41.jpg)
Ophthalmic solutions of beta-blockers
for treatment of glaucoma Beta-blockers in ophthalmic solutions are used in treatment of glaucoma.
Beta-blockers presented in ophthalmic formulations are betaxolol, befunolol, carteolol, metipranolol, timolol and levobunolol.
![Page 42: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/42.jpg)
Adverse effects
Aggravation of congestive heart failure.
Congestive heart failure is both an indication and a contraindication to the use of beta-blockers.
![Page 43: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/43.jpg)
In any case, starting a beta-blocking treatment cannot be done without a rigorous analysis of the state of the patient and necessitates a close monitoring.
![Page 44: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/44.jpg)
Aggravation of bradyarrythmia; bradycardia, atrioventricular blocks are contraindications to their prescription.
Coldness of the extremities , possible aggravation of arteritis, especially with nonselective beta-blockers but sometimes also with beta-1 selective.
![Page 45: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/45.jpg)
A ggravation of asthmatic disease, especially with nonselective beta-blockers - but also sometimes with beta-1selective blockers.
![Page 46: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/46.jpg)
Worsened risk of anaphylactic shock by partial inhibition of mechanisms opposed to it
![Page 47: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/47.jpg)
Metabolic disorders
Increase in triglycerides
-increase in cholesterol and the VLDL (very low density lipoproteins); hypoglycemia in diabetics
-raised risk of developing a type II diabetes after antihypertensive treatment during several years by beta-blockers.
![Page 48: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/48.jpg)
Various, rare disorders
immunological disorders, lupus, fibroses.
Rebound of symptoms at abrupt discontinuation of beta-blockers >>>>>>>>>>>>> tachycardia, arterial hypertension, fainting, sweats, nervousness , especially risk of angina, myocardial infarction and sudden death.
![Page 49: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/49.jpg)
Diffusion in the body after topical use of ophthalmic solutions.
Ophthalmic solutions of beta-blockers have few local adverse effects, irritation for example, but can have general adverse effects after systemic diffusion.
They frequently elicit bradycardia, asthma, in the elderly
Elimination in milk >>>>>>>>> Beta-blocker use is contraindicated during lactation.
![Page 50: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/50.jpg)
In overdoses, accidental or voluntary, beta-blockers cause hypotension, bradycardia, heart rhythm disorders and shock.
![Page 51: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/51.jpg)
A drug likely to reduce disorders caused by beta-blockers is glucagon because it stimulates adenylcyclase despite the blockade of beta-receptors.
![Page 52: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/52.jpg)
Poisoning by beta-blockers with membrane stabilizing activity appears more difficult to treat than that elicited by beta-blockers which do not have this activity
![Page 53: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/53.jpg)
DRUG SELECTIVITY Partial-agonist activity
Local anesthetic effect
Lipid solubility
Half life
Acebutolol B-1 + + Low 3-4 h
Atenolol B-1 - - Low 6-9 h
Esmolol B-1 - - Low 10 min
Carvedilol - - - ? 7-10 h
Labetalol - + + Mod 5 h
Metoprolol B-1 - + Mod 3-4 h
Nadolol - - - Low 14-24 h
Pindolol - + + Mod 3-4 h
Propranolol - - + High 4-6 h
Timolol - - - Mod 4-5 h
Characteristics of beta-blockers
![Page 54: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/54.jpg)
Therapeutic uses of beta blockers
![Page 55: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/55.jpg)
Used for HYPERTENSION
Drugs (atenolol, propranolol, metoprolol, timolol)
Effect > reduced cardiac out put, reduced renin secretion
![Page 56: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/56.jpg)
Angina pectoris
Drugs…….propranolol, nadolol
Effects…… -ve chrn: and –ve ionot: effect
![Page 57: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/57.jpg)
Arrhythmia prophylaxis after MI
Propranolol, metoprolol, timolol
Effects…….reduced automaticity of all cardiac pacemakers
![Page 58: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/58.jpg)
Supraventricular tachycardias
Propranolol, esmolol, acebutolol
Effects…..slowed AV conduction velocity
![Page 59: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/59.jpg)
Hepertropic cardiomyopathy
Propranolol
Effects…..slowed rate of cardiac contraction
![Page 60: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/60.jpg)
Migraine
Propranolol
Effects….vasodilation
![Page 61: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/61.jpg)
Thyroid storm, thyrotoxicosis
Propranolol
Effects….. Reduced cardiac rate & arrhythmogenesis
![Page 62: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/62.jpg)
Glaucoma
Timolol
Effects ……… reduced secretion of aqueous humor
![Page 63: Beta blockers](https://reader033.fdocuments.in/reader033/viewer/2022061604/554b34c2b4c905ce088b5207/html5/thumbnails/63.jpg)
Other drugs used in glaucoma
PGsCholinomimeticsAlpha agonists…..adrenaline, dipivefrinAlpha-2 selective
antagonists…..apraclonidine, brimonidineDiuretics …acetazolamide, dorzolamide